Association between polymorphisms of the DNA repair genes XRCC1 and hOGG1 and type 2 diabetes mellitus in the polish population

Polskie Archiwum Medycyny Wewnetrznej

Volumn 119, Issue 3, 2009, Pages 122-128

  Kasznicki, Jacek ^a   Krupa, Renata ^a   Błasiak, Janusz ^a   Drzewoski, Józef ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

DNA repair; Gene polymorphism; hOGG1; Type 2 diabetes mellitus; XRCC1

Indexed keywords

GLUCOSE; XRCC1 PROTEIN;

ADULT; AGED; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DAMAGE; DNA POLYMORPHISM; DNA REPAIR; EXCISION REPAIR; FEMALE; GENE; GENE ACTIVITY; GENE FREQUENCY; GENE INTERACTION; GENOTYPE; GLUCOSE METABOLISM; HUMAN; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OGG1 GENE; POLAND; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 64149087142     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.626     Document Type: Article

References (39)

1. Kuroki T, Isshiki K, King GL. Oxidative stress: the lead or supporting actor in the pathogenesis of diabetic complications. J Am Soc Nephrol. 2003; 14:S216-S220.
2. Collins AR, Gedik CM, Olmedilla B, et al. Oxidative DNA damage measured in human lymphocytes: large differences between sexes and between countries, and correlations with heart disease mortality. FASEB J. 1998;12:1397-1400.
3. Collins AR, Raslova K, Somorovska M, et al. DNA damage in diabetes: correlation with a clinical marker. Free Radic Biol Med. 1998; 25: 373-377.
4. Oandona P, Thusu K, Cook S, et al. Oxidative damage to DNA in diabetes mellitus. Lancet. 1996; 347:444-445.
5. Merkel P, Khoury N, Bertolotto C, et al. Insulin and glucose regulate the expression of the DNA repair enzyme XPD. Mol Cell Endocrinol. 2003; 201:75-85.
6. Blasiak J, Arabski M, Krupa R, et al. DNA damage and repair in type 2 diabetes mellitus. Mutat Res. 2004; 554: 297-304.
7. Mohrenweiser HW, Jones IM. Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation? Mutat Res. 1998; 400:15-24.
8. Thompson LH, West MG. XRCC1 keeps DNA from getting stranded. Mutat Res. 2000; 459; 1-18.
9. Abdel-Rahman SZ, El-Zein RA. The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by tobacco-specific nitrosamine NNK. Cancer Lett. 2000; 159:63-71.
10. Ishida T, Hippo Y, Nakahori Y, et al. Structure and chromosome location of human 0GG1, Cytogenet Cell Genet. 1999; 85: 232-236.
11. Monden Y, Arai T, Asano M, et al. Human MMH (0GG1) type 1a protein is a major enzyme for repair of 8-hydroxyguanine lesions in human cells. Biochem Biophys Res Commun. 1999; 258: 605-610.
12. Duell EJ, Millikan RC, Pittman GS, et al. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev. 2001;10:217-222
13. Figeueiredo JC, Knight JA, Briollais L, et al. Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev. 2004; 13:583-591.
14. Smith TR, Miller MS, Lohman K, et al. Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer Cancer Lett. 2003; 190: 183-190.
15. Dulic A, Bates PA, Zhang X, et al. BRCT domain interactions in the heterodimeric DNA repair protein XRCC1-DNA ligase III. Biochemistry. 2001;40:5906-5913.
16. Kohno T, Shinmura K, Tosaka M, et al: Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene. 1998; 16:3219-3225.
17. World Health Organization Study Group. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Tech Rep Ser WHO/NCD/NCS/99, 2nd ed. World Health Organization, Geneva, 1999.
18. Le Marchand L, Donlon T, Lum-Jones A, et al. Association of the hOGGI Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2002; 11:409-412.
19. Matullo G, Guarrera S, Carturan S, et al. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer. 2001; 92: 562-567.
20. Matullo G, Palli D, Peluso M, et al. XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis. 2001; 22: 1437-1445.
21. Lee JM, Lee YC, Yang SY, et al. Genetic polymorphisms of XRCC1 and risk of the esophageal cancer. Int J Cancer. 2001; 95: 240-246.
22. Ratnasinghe D, Yao SX, Tangrea JA, et al. Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 2001; 10:119-123.
23. Stem MC, Umbach DM, van Gils CH, et al. DNA repair gene XRCC1 polymorphisms, smoking and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2001; 10:125-131.
24. Park J, Chen L, Tockman MS, et al. The human 8-oxoguanine DNA N-glycosylase 1 (hOGGI) DNA repair enzyme and its association with lung cancer risk. Pharmacogenetics. 2004; 14:103-109.
25. Wikman H, Risch A, Klimek F, et al. hOGGI polymorphism and loss of heterozygosity (L0H): significance for lung cancer susceptibility in a Caucasian population. Int J Cancer. 2000; 88: 932-937.
26. Xu J, Zheng SL, Turner A, et al. Associations between hOGGI sequence variants and prostate cancer susceptibility. Cancer Res. 2002; 62: 2253-2257.
27. Caimi G, Carollo C, Lo Presti R. Diabetes mellitus: oxidative stress and wine. Curr Med Res Opin. 2003; 19: 581-586.
28. Dizdaroglu M, Dirksen ML, Jiang HX, et al. lonizing-radiation-induced damage in the DNA of cultured human cells. Identification of 8,5-cyclo-2-deoxyguanosine. Biochem J. 1987: 241: 929-932.
29. Dizdaroglu M. Free-radical-induced formation of an 8,5'-cyclo- 2'deoxyguanosine moiety in deoxyribonucleic acid. Biochem J. 1986; 238: 247-254.
30. Pitozzi V, Giovannelli L, Bardini G, et al. Oxidative DNA damage in peripheral blood cells in type 2 diabetes mellitus: higher vulnerability of polymorphonuclear leukocytes. Mutat Res. 2003; 529:129-133.
31. Dincer Y, Akcay T, Alademir Z, et al. Assessment of DNA base oxidation and glutathione level in patients with type 2 diabetes. Mutat Res. 2002;505:75-81.
32. Nair J, De Flora S, Izzotti A, et al. Lipid peroxidation-derived etheno-DNA adducts in human atherosclerotic lesions. Mutat Res. 2007; 121: 95-105.
33. Hayaishi-Okano R, Yamasaki Y, Kajimoto Y, et al. Association of NAD(P)H oxidase p22 phox gene variation with advanced carotid atherosclerosis in Japanese type 2 diabetes. Diabetes Care. 2003; 26:458-463.
34. Nishikawa T, Sasahara T, Kiritoshi S, et al. Evaluation of urinary 8-hydroxydeoxy-ganosine as a novel biomarker of macrovascular complications in type 2 diabetes. Diabetes Care. 2003; 26: 1507-1512.
35. Guven M, Guven GS, Ozaydin A, et al. DNA repair gene XRCC1 and XPD polymorphisms and their association with coronary artery disease risks and micronucleus frequency. Heart Vessels. 2007; 22:356-360.
36. Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology. 2007; 132:2208-2225.
37. Saydah SH, Loria CM, Eberhardt MS, et al. Abnormal glucose tolerance and the risk of cancer death in the United States. Am J Epidemiol. 2003;157:1092-1100.
38. Schiel R, Beltschikow W, Steiner T, et al. Diabetes, insulin, and risk of cancer. Methods Find Exp Clin Pharmacol. 2006; 28: 69-175.
39. Andreassi MG, Botto N. DNA damage as a new emerging risk factor in atherosclerosis. Trends Cardiovasc Med. 2003; 13: 270-275.